Get startedLog in
    Picture of Paradigm Biopharmaceuticals logo

    PAR — Paradigm Biopharmaceuticals News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeSmall Cap
    All News

    Brief: Paradigm Biopharma Gets Australian Ethics Approval For Phase 3 Trial For PARA_OA_002

    Picture of Paradigm Biopharmaceuticals logoParadigm Biopharmaceuticals
    24/09/2021 24:04
    Sept 24 (Reuters) - Paradigm Biopharmaceuticals Ltd
 PAR.AX :
    * AUS ETHICS APPROVAL RECEIVED FOR PHASE 3 TRIAL-PAR.AX
    * GETS AUSTRALIAN ETHICS APPROVAL FOR PARA_OA_002 PIVOTAL
PHASE 3
CLINICAL TRIAL IN PARTICIPANTS WITH KNEE OA

Source text for Eikon:  ID:nASX6Qjhyx 
Further company coverage:  PAR.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Paradigm Biopharmaceuticals

    See all news